Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amin Addetia

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Biorxiv : the Preprint Server for Biology|April 14, 2021
Structural basis for broad sarbecovirus neutralization by a human monoclonal antibodyM Alejandra Tortorici, Nadine Czudnochowski, Tyler N Starr, et al.
Biorxiv : the Preprint Server for Biology|April 14, 2021
Antibodies to the SARS-CoV-2 receptor-binding domain that maximize breadth and resistance to viral escapeTyler N Starr, Nadine Czudnochowski, Fabrizia Zatta, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2021
Multivalent designed proteins protect against SARS-CoV-2 variants of concernAndrew C Hunt, James Brett Case, Young-Jun Park, et al.
Science Translational Medicine|April 12, 2022
Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in miceAndrew C Hunt, James Brett Case, Young-Jun Park, et al.
Science (New York, N.Y.)|October 20, 2022
Imprinted antibody responses against SARS-CoV-2 Omicron sublineagesYoung-Jun Park, Dora Pinto, Alexandra C Walls, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2022
Imprinted antibody responses against SARS-CoV-2 Omicron sublineagesYoung-Jun Park, Dora Pinto, Alexandra C Walls, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Therapeutic and vaccine-induced cross-reactive antibodies with effector function against emerging Omicron variantsAmin Addetia, Luca Piccoli, James Brett Case, et al.
Cell|October 9, 2024
A potent pan-sarbecovirus neutralizing antibody resilient to epitope diversificationLaura E Rosen, M Alejandra Tortorici, Anna De Marco, et al.
Nature|July 14, 2021
SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escapeTyler N Starr, Nadine Czudnochowski, Zhuoming Liu, et al.
Nature|August 30, 2023
Neutralization, effector function and immune imprinting of Omicron variantsAmin Addetia, Luca Piccoli, James Brett Case, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Biorxiv : the Preprint Server for Biology|April 14, 2021
Structural basis for broad sarbecovirus neutralization by a human monoclonal antibodyM Alejandra Tortorici, Nadine Czudnochowski, Tyler N Starr, et al.
Biorxiv : the Preprint Server for Biology|April 14, 2021
Antibodies to the SARS-CoV-2 receptor-binding domain that maximize breadth and resistance to viral escapeTyler N Starr, Nadine Czudnochowski, Fabrizia Zatta, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2021
Multivalent designed proteins protect against SARS-CoV-2 variants of concernAndrew C Hunt, James Brett Case, Young-Jun Park, et al.
Science Translational Medicine|April 12, 2022
Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in miceAndrew C Hunt, James Brett Case, Young-Jun Park, et al.
Science (New York, N.Y.)|October 20, 2022
Imprinted antibody responses against SARS-CoV-2 Omicron sublineagesYoung-Jun Park, Dora Pinto, Alexandra C Walls, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2022
Imprinted antibody responses against SARS-CoV-2 Omicron sublineagesYoung-Jun Park, Dora Pinto, Alexandra C Walls, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Therapeutic and vaccine-induced cross-reactive antibodies with effector function against emerging Omicron variantsAmin Addetia, Luca Piccoli, James Brett Case, et al.
Cell|October 9, 2024
A potent pan-sarbecovirus neutralizing antibody resilient to epitope diversificationLaura E Rosen, M Alejandra Tortorici, Anna De Marco, et al.
Nature|July 14, 2021
SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escapeTyler N Starr, Nadine Czudnochowski, Zhuoming Liu, et al.
Nature|August 30, 2023
Neutralization, effector function and immune imprinting of Omicron variantsAmin Addetia, Luca Piccoli, James Brett Case, et al.
Pageof 6